Disconnected by design: analytic approach in treatment networks having no common comparator

Rejoinder to the discussion of “a Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons,” by S. Dias and A. E. Ades

(2015) Hwanhee Hong et al.   Research Synthesis Methods

Absolute or relative effects? Arm-based synthesis of trial data

(2015) S. Dias et al.   Research Synthesis Methods

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

(2014) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C

(2013) Nihar Shah et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Evidence Synthesis for Decision Making 5

(2013) Sofia Dias et al.   MEDICAL DECISION MAKING

Evidence Synthesis for Decision Making 3

(2013) Sofia Dias et al.   MEDICAL DECISION MAKING

Evidence Synthesis for Decision Making 1

(2013) Sofia Dias et al.   MEDICAL DECISION MAKING

Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons

(2012) Jeroen P. Jansen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

(2012) Anas Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

Evidence Synthesis for Decision Making 2

(2012) Sofia Dias et al.   MEDICAL DECISION MAKING

Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research

(2012) James E. Signorovitch et al.   VALUE IN HEALTH

Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions

(2012) Jeffrey C. Valentine et al.   Research Synthesis Methods

Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer

(2011) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

(2011) David C. Hoaglin et al.   VALUE IN HEALTH

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

(2011) Jeroen P. Jansen et al.   VALUE IN HEALTH

Prognostic versus predictive value of biomarkers in oncology

(2008) C.N.A.M. Oldenhuis et al.   EUROPEAN JOURNAL OF CANCER

Reasons or excuses for avoiding meta-analysis in forest plots

(2008) John P A Ioannidis et al.   BMJ-British Medical Journal

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal